Liu Xueyuan et al. confirmed that the Tiao Xin preparation reduced the expression of GFAP and APP mRNA (75l/770) in AD models, which inhibited the activation of glial cells and reduced inflammatory reactions and the large amount of amyloid-β protein deposition to reduce the formation of SPs [5]. The gene discussed is GFAP; the disease is Alzheimer disease.